Filing Details
- Accession Number:
- 0001179110-21-000368
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2021-01-06 19:06:20
- Reporting Period:
- 2020-11-10
- Accepted Time:
- 2021-01-06 19:06:20
- Original Submission Date:
- 2020-11-12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1735438 | Meiragtx Holdings Plc | MGTX | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1742771 | Stuart Naylor | 450 East 29Th Street, 14Th Floor New York NY 10016 | Chief Development Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2020-11-10 | 4,851 | $15.00 | 450,017 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019.
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.01, inclusive.
- The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Due to a reporting error by the reporting person's brokerage firm, this Form 4 is being amended to reflect the correct number of shares sold by the reporting person on the transaction date.